FEATURED May 25, 2026A Program with Heart (and Many Vessels)
FEATURED June 25, 2026What the Immune System Does When You’re Not Sick—and Why It Matters for Aging
FEATURED September 08, 2026Immune Cells’ Role as Quality Control Boosts Tissue Health
- September 10, 2026
Hwa Joins MD-PhD Program as an Associate Director
- September 09, 2026
Libreros Elected Associate Councilor of Society for Leukocyte Biology
Vascular Biology and Therapeutics Program
An interdisciplinary program combining the strengths of Yale’s basic science and clinician faculty
The Vascular Biology and Therapeutics (VBT) Program is the first and largest interdepartmental program at Yale School of Medicine (YSM). VBT faculty are recognized as some of the best in the world, consistently making national and international scientific contributions in the field of vascular biology.
The program integrates groundbreaking discoveries in vascular biology with closely allied clinical programs in Medicine and Surgery to enhance the diagnosis and treatment of cardiovascular disorders. The VBT program integrates 56 research laboratories, 17 primary labs housed at the Amistad Research Building, and 39 affiliated laboratories. These faculty labs are from 18 departments/divisions/sections in two schools (Medical School and Faculty Arts and Sciences).
Areas of Focus
The VBT program focuses on five broad areas of investigation:
- Immunobiology and Metabolism in Cardiovascular Disease
- Novel Mechanism of Cardiovascular Disease
- Human Genetics, Novel Technologies and Cardiovascular Imaging
- Vascular Aging and Regeneration
- Neurovascular Disease
Upcoming VBT Events
Sep 202621Monday
- Yale OnlyFEATUREDMatthew Rodeheffer, PhD
Sep 202628Monday
- Yale OnlyFEATUREDEric Schmidt, MD
Oct 202615Thursday
- Organization OnlyFEATUREDBrian Annex, MD - Klaus Ley, MD - Allison E. Gaffey, PhD - Daniel Jane-Wit, MD, PhD - John Hwa, MD, PhD, FRACP - Bong Ihn Koh - Themis Kyriakides, PhD - Mehran M Sadeghi, MD - Dianqing (Dan) Wu, PhD